PL2958558T3 - Sposoby i kompozycje do leczenia białaczki - Google Patents
Sposoby i kompozycje do leczenia białaczkiInfo
- Publication number
- PL2958558T3 PL2958558T3 PL14754927T PL14754927T PL2958558T3 PL 2958558 T3 PL2958558 T3 PL 2958558T3 PL 14754927 T PL14754927 T PL 14754927T PL 14754927 T PL14754927 T PL 14754927T PL 2958558 T3 PL2958558 T3 PL 2958558T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- methods
- treating leukemia
- leukemia
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361767211P | 2013-02-20 | 2013-02-20 | |
| PCT/US2014/017285 WO2014130619A2 (en) | 2013-02-20 | 2014-02-20 | Methods and compositions for treating leukemia |
| EP14754927.3A EP2958558B1 (en) | 2013-02-20 | 2014-02-20 | Methods and compositions for treating leukemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2958558T3 true PL2958558T3 (pl) | 2018-12-31 |
Family
ID=51391965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14754927T PL2958558T3 (pl) | 2013-02-20 | 2014-02-20 | Sposoby i kompozycje do leczenia białaczki |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9403747B2 (pl) |
| EP (1) | EP2958558B1 (pl) |
| JP (1) | JP6501123B2 (pl) |
| KR (1) | KR102054038B1 (pl) |
| CN (2) | CN105246470A (pl) |
| AU (1) | AU2014218938B2 (pl) |
| BR (1) | BR112015019924A2 (pl) |
| CA (1) | CA2901745A1 (pl) |
| DK (1) | DK2958558T3 (pl) |
| ES (1) | ES2687286T3 (pl) |
| HK (2) | HK1219884A1 (pl) |
| MX (1) | MX2015010728A (pl) |
| PL (1) | PL2958558T3 (pl) |
| TW (1) | TWI597061B (pl) |
| WO (1) | WO2014130619A2 (pl) |
| ZA (1) | ZA201506330B (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2961932T3 (es) * | 2016-02-17 | 2024-03-14 | Golden Biotechnology Corp | Composiciones y métodos para tratar el cáncer de hígado |
| EP3454866A4 (en) * | 2016-05-13 | 2020-01-08 | Golden Biotechnology Corporation | METHOD AND COMPOSITIONS FOR TREATING ADVANCED NON-SMALL CELL LUNG CANCER |
| TWI601535B (zh) * | 2016-06-23 | 2017-10-11 | 台灣利得生物科技股份有限公司 | 牛樟段木栽培牛樟芝子實體及固態培養菌絲體水及乙醇萃取物之組合物應用於抗癌藥輔助劑 |
| CN107540641A (zh) * | 2016-06-29 | 2018-01-05 | 彭朗 | 一种新的有机酯类化合物及其制备方法和医药用途 |
| US10314241B1 (en) * | 2016-09-14 | 2019-06-11 | T. Scott Dunn | Airborne vegetation cutting assembly |
| US11406605B2 (en) * | 2017-12-20 | 2022-08-09 | Golden Biotechnology Corporation | Therapeutic compositions for treating pancreatic cancer |
| WO2020176436A1 (en) * | 2019-02-25 | 2020-09-03 | Arjil Biotech Holding Company Limited | Method and composition for inhibiting virus infection |
| US11548069B2 (en) | 2019-05-20 | 2023-01-10 | Wisconsin Alumni Research Foundation | Three-dimensional printer laminating fusible sheets |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3993073A (en) | 1969-04-01 | 1976-11-23 | Alza Corporation | Novel drug delivery device |
| US3598122A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US4069307A (en) | 1970-10-01 | 1978-01-17 | Alza Corporation | Drug-delivery device comprising certain polymeric materials for controlled release of drug |
| US3731683A (en) | 1971-06-04 | 1973-05-08 | Alza Corp | Bandage for the controlled metering of topical drugs to the skin |
| US3742951A (en) | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
| US3996934A (en) | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
| BE795384A (fr) | 1972-02-14 | 1973-08-13 | Ici Ltd | Pansements |
| US3921636A (en) | 1973-01-15 | 1975-11-25 | Alza Corp | Novel drug delivery device |
| US3993072A (en) | 1974-08-28 | 1976-11-23 | Alza Corporation | Microporous drug delivery device |
| US3972995A (en) | 1975-04-14 | 1976-08-03 | American Home Products Corporation | Dosage form |
| US4077407A (en) | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
| US4031894A (en) | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
| US4060084A (en) | 1976-09-07 | 1977-11-29 | Alza Corporation | Method and therapeutic system for providing chemotherapy transdermally |
| US4201211A (en) | 1977-07-12 | 1980-05-06 | Alza Corporation | Therapeutic system for administering clonidine transdermally |
| JPS5562012A (en) | 1978-11-06 | 1980-05-10 | Teijin Ltd | Slow-releasing preparation |
| US4230105A (en) | 1978-11-13 | 1980-10-28 | Merck & Co., Inc. | Transdermal delivery of drugs |
| US4291015A (en) | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| US5633009A (en) | 1990-11-28 | 1997-05-27 | Sano Corporation | Transdermal administration of azapirones |
| US5665378A (en) | 1994-09-30 | 1997-09-09 | Davis; Roosevelt | Transdermal therapeutic formulation |
| US6923983B2 (en) | 1996-02-19 | 2005-08-02 | Acrux Dds Pty Ltd | Transdermal delivery of hormones |
| US6929801B2 (en) | 1996-02-19 | 2005-08-16 | Acrux Dds Pty Ltd | Transdermal delivery of antiparkinson agents |
| US5905089A (en) * | 1997-04-14 | 1999-05-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Use of sesquiterpene lactones for treatment of severe inflammatory disorders |
| US5869090A (en) | 1998-01-20 | 1999-02-09 | Rosenbaum; Jerry | Transdermal delivery of dehydroepiandrosterone |
| US6946144B1 (en) | 1998-07-08 | 2005-09-20 | Oryxe | Transdermal delivery system |
| US20070287672A1 (en) * | 2004-04-20 | 2007-12-13 | Donald Creighton | Macromolecular Gsh-Activiated Glyoxylase I Inhibitors |
| WO2006039414A2 (en) * | 2004-09-30 | 2006-04-13 | Ariad Gene Therapeutics, Inc. | Treatment method |
| CN101343247B (zh) * | 2007-07-12 | 2011-01-19 | 国鼎生物科技股份有限公司 | 牛樟芝的环己烯酮萃取物 |
| TW200918498A (en) * | 2007-10-19 | 2009-05-01 | Golden Biotechnology Corp | Novel compound isolated from Antrodia camphorate extracts |
| TWI389699B (zh) | 2009-02-13 | 2013-03-21 | 高雄醫學大學 | 用於誘導細胞凋亡之樟芝子實體乙醇萃取物及其製備方法 |
| TW201102075A (en) * | 2009-07-09 | 2011-01-16 | Golden Biotechnology Corp | Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of pancreatic cancer |
| TW201109013A (en) * | 2009-09-09 | 2011-03-16 | Golden Biotechnology Corp | Cyclohexenone chemical compounds of Antrodia cinnamomea for suppressing the growth of the Lymphoma tumor cell |
| EP2329816B1 (en) | 2009-11-26 | 2016-04-13 | National Taiwan University | An anti-cancer active substance from antrodia camphorata, method for preparing the same and use thereof |
| CN102232942B (zh) * | 2010-05-06 | 2013-03-27 | 国鼎生物科技股份有限公司 | 用于抑制淋巴癌肿瘤细胞生长的牛樟芝环己烯酮化合物 |
| US8309611B2 (en) | 2010-09-20 | 2012-11-13 | Golden Biotechnology Corporation | Methods and compositions for treating lung cancer |
| CN103402999A (zh) * | 2010-11-24 | 2013-11-20 | 埃克塞里艾克西斯公司 | 作为PI3K/mTOR抑制剂的苯并氧氮杂卓及其使用和生产方法 |
| TWI444189B (zh) * | 2011-05-31 | 2014-07-11 | Mackay Memorial Hospital | 羊毛甾醇-8,24-二烯-3β,15α,21-三醇抑制腫瘤細胞生長之用途 |
| CN103796647A (zh) * | 2011-06-10 | 2014-05-14 | 国鼎生物科技股份有限公司 | 用于治疗脑癌的方法和组合物 |
| TWI484954B (zh) * | 2011-10-11 | 2015-05-21 | New Bellus Entpr Co Ltd | 用於治療癌症之醫藥組合物 |
| US20150018296A1 (en) * | 2013-03-15 | 2015-01-15 | Golden Biotechnology Corporation | Therapeutic methods and compositions utilizing cyclohexenone compounds |
-
2014
- 2014-02-19 TW TW103105416A patent/TWI597061B/zh active
- 2014-02-20 WO PCT/US2014/017285 patent/WO2014130619A2/en not_active Ceased
- 2014-02-20 CN CN201480022525.3A patent/CN105246470A/zh active Pending
- 2014-02-20 EP EP14754927.3A patent/EP2958558B1/en active Active
- 2014-02-20 ES ES14754927.3T patent/ES2687286T3/es active Active
- 2014-02-20 DK DK14754927.3T patent/DK2958558T3/en active
- 2014-02-20 MX MX2015010728A patent/MX2015010728A/es unknown
- 2014-02-20 CN CN201810367184.3A patent/CN108309961A/zh active Pending
- 2014-02-20 BR BR112015019924A patent/BR112015019924A2/pt not_active IP Right Cessation
- 2014-02-20 HK HK16107933.7A patent/HK1219884A1/zh unknown
- 2014-02-20 KR KR1020157025170A patent/KR102054038B1/ko active Active
- 2014-02-20 AU AU2014218938A patent/AU2014218938B2/en active Active
- 2014-02-20 CA CA2901745A patent/CA2901745A1/en not_active Abandoned
- 2014-02-20 JP JP2015558939A patent/JP6501123B2/ja active Active
- 2014-02-20 PL PL14754927T patent/PL2958558T3/pl unknown
- 2014-02-20 US US14/184,982 patent/US9403747B2/en active Active
-
2015
- 2015-08-28 ZA ZA2015/06330A patent/ZA201506330B/en unknown
-
2018
- 2018-11-15 HK HK18114626.3A patent/HK1255453A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150120424A (ko) | 2015-10-27 |
| CN105246470A (zh) | 2016-01-13 |
| WO2014130619A2 (en) | 2014-08-28 |
| ZA201506330B (en) | 2016-10-26 |
| HK1255453A1 (zh) | 2019-08-16 |
| EP2958558B1 (en) | 2018-06-13 |
| CN108309961A (zh) | 2018-07-24 |
| CA2901745A1 (en) | 2014-08-28 |
| EP2958558A4 (en) | 2016-08-10 |
| JP6501123B2 (ja) | 2019-04-17 |
| KR102054038B1 (ko) | 2019-12-09 |
| AU2014218938B2 (en) | 2018-12-06 |
| WO2014130619A3 (en) | 2014-10-16 |
| EP2958558A2 (en) | 2015-12-30 |
| MX2015010728A (es) | 2016-04-11 |
| HK1219884A1 (zh) | 2017-04-21 |
| BR112015019924A2 (pt) | 2017-07-18 |
| AU2014218938A1 (en) | 2015-09-10 |
| TWI597061B (zh) | 2017-09-01 |
| US9403747B2 (en) | 2016-08-02 |
| DK2958558T3 (en) | 2018-09-24 |
| JP2016509058A (ja) | 2016-03-24 |
| TW201446240A (zh) | 2014-12-16 |
| US20150025135A1 (en) | 2015-01-22 |
| ES2687286T3 (es) | 2018-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273205A (en) | Preparations and methods | |
| IL281058A (en) | Compositions and methods for treating anemia | |
| GB2520795B (en) | Compositions and methods | |
| IL246023B (en) | Methods and preparations for the treatment of age-related conditions | |
| IL245281A0 (en) | Methods and preparations for the treatment of cancer | |
| SMT201900635T1 (it) | Composizioni e metodi di attivazione della segnalazione dipendente dallo "stimolatore di geni interferone" | |
| IL245778B (en) | Methods and preparations for the treatment of hemophilia | |
| SG10201707319UA (en) | Compositions and methods for treating mpsi | |
| ZA201505390B (en) | Compositions and methods for treating pests | |
| GB201308072D0 (en) | Compositions and methods | |
| ZA201506330B (en) | Methods and compositions for treating leukemia | |
| GB201305813D0 (en) | Compositions and methods | |
| EP3052102A4 (en) | Compositions and methods for treating cancers | |
| IL239680B (en) | Preparations and methods for polynucleotide transfection | |
| SG11201510300RA (en) | Compositions and methods for treating skin | |
| IL243022B (en) | Compositions and methods for post-harvest treatment | |
| GB201302474D0 (en) | Compositions and methods for treating biofilms | |
| GB201302472D0 (en) | Compositions and methods for treating biofilms | |
| GB201302475D0 (en) | Compositions and methods for treating biofilms | |
| GB201322617D0 (en) | Methods and compositions | |
| GB201312393D0 (en) | Compositions and Methods | |
| GB201304271D0 (en) | Composition and apparatus |